Livonibe 200mg Tablet

About

Livonibe 200mg Tablet is a novel oral targeted therapy designed to selectively inhibit specific tyrosine kinases involved in cellular proliferation and angiogenesis. This mechanism of action disrupts key signaling pathways that drive tumor growth and metastasis in various solid tumors. By targeting these aberrant pathways, Livonibe aims to halt disease progression and improve patient outcomes. It is typically prescribed for patients with advanced or metastatic cancers who have specific molecular markers or have progressed on prior therapies. The drug's efficacy is often linked to its ability to overcome resistance mechanisms seen with other treatments, offering a new therapeutic avenue.

Uses

• Treatment of advanced renal cell carcinoma.
• Management of differentiated thyroid cancer.
• Therapy for hepatocellular carcinoma.
• Treatment of certain types of non-small cell lung cancer.

Directions For Use

Take Livonibe 200mg Tablet orally once daily with or without food, as directed by your physician. Do not crush, chew, or split the tablet.

Benefits

• Targets specific cancer-driving pathways.
• May improve progression-free survival.
• Offers an oral administration option.
• Effective in various advanced solid tumors.
• Potentially overcomes drug resistance.
• Provides a new therapeutic option for patients.

Side Effects

• Fatigue
• Diarrhea
• Nausea
• Vomiting
• Hypertension
• Hand-foot syndrome
• Rash
• Anorexia
• Weight loss
• Proteinuria
• Hypothyroidism
• Headache

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may exacerbate certain side effects or interact with the medication.
• Pregnancy - Livonibe is contraindicated in pregnancy due to potential fetal harm. Effective contraception is required during treatment and for a period after.
• Breastfeeding - Breastfeeding is not recommended during Livonibe treatment and for a specified period after the last dose, due to potential harm to the infant.
• Liver - Use with caution in patients with hepatic impairment; dose adjustments may be necessary. Regular liver function monitoring is crucial.
• Kidney - Use with caution in patients with renal impairment; dose adjustments may be required based on the severity of kidney dysfunction.
• Lung - Monitor for new or worsening pulmonary symptoms, as interstitial lung disease or pneumonitis can occur rarely.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.